TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1355209

Group type: EXPERIMENTAL
Intervention: High energy supplement (HE) providing 1950 kJ (465 kcal) during the last trimester of pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low energy supplement (LE) providing 218 kJ (52 kcal) during the last trimester of pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High energy supplement (HE)
Number of subjects: 0
Study: 6347428

Group type: EXPERIMENTAL
Intervention: Aspirin alone (975 mg/day)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Aspirin and dipyridamole (225 mg/day)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 176
Study: 30352778

Group type: EXPERIMENTAL
Intervention: Omega-3 FA (3.36 eicosapentaenoic acid [EPA] + docosahexaenoic acid)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (4 g olive oil)
Number of subjects: 49
Study: 27805266

Group type: EXPERIMENTAL
Intervention: Sexualized appearance of the victim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-sexualized appearance of the victim
Number of subjects: 0
Study: 25515725

Group type: EXPERIMENTAL
Intervention: Switching to prasugrel or ticagrelor from clopidogrel
Number of subjects: 11999

Group type: COMPARATOR
Intervention: Continuation on prasugrel or ticagrelor
Number of subjects: 11999

Group type: COMPARATOR
Intervention: Continuation on clopidogrel
Number of subjects: 11999
Study: 24463756

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levetiracetam
Number of subjects: 60
Study: 22962202

Group type: EXPERIMENTAL
Intervention: Tier 1 Program of Project P.A.T.H.S.
Number of subjects: 128
Study: 19291926

Group type: EXPERIMENTAL
Intervention: Betamethasone injection (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs) (Group B)
Number of subjects: 32
Study: 17236859

Group type: EXPERIMENTAL
Intervention: Virtual-reality training with an angled-telescope simulator (EndoTower; Verefi Technologies, Elizabethtown, PA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 19
Study: 15007746

Group type: EXPERIMENTAL
Intervention: Apparent diffusion coefficient (ADC) measurement
Number of subjects: 12

Group type: COMPARATOR
Intervention: Motion correction
Number of subjects: 12
Study: 11506215

Group type: EXPERIMENTAL
Intervention: Individually designed physical training programme
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Work-place stress management
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 282
Study: 9802368

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide turbohaler (1600 micrograms)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral prednisolone (2 mg/kg)
Number of subjects: 22
Study: 7949230

Group type: EXPERIMENTAL
Intervention: Diabetic children
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 2462442

Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 28966208

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27513296

Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy (SET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular revascularization (ER)
Number of subjects: 0
Study: 24881803

Group type: EXPERIMENTAL
Intervention: Needle-free jet injector (Stratis; PharmaJet)
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Needle and syringe
Number of subjects: 1250
Study: 24220660

Group type: EXPERIMENTAL
Intervention: KT intervention including a three-day skills training workshop and multifaceted workplace supports (paid EBP time, mentoring, system changes, access to an online research synthesis tool)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 135
Study: 20631214

Group type: EXPERIMENTAL
Intervention: High-error trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Some high-error trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-error trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixture of high- and low-error trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Congruent force field
Number of subjects: 0

Group type: COMPARATOR
Intervention: Incongruent force field
Number of subjects: 0
Study: 17545300

Group type: EXPERIMENTAL
Intervention: Bonded first molar tubes (n = 181) bonded with Rely‐A‐Bond after a 30‐second etch
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cemented bands (n = 186) with Intact glass ionomer cement (GIC)
Number of subjects: 110
Study: 15136063

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy (Probucol and Ticlopidine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11214732

Group type: EXPERIMENTAL
Intervention: Seal oil (SO) 15 mL daily for 14 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cod-liver oil (CLO) 15 mL daily for 14 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no dietary supplement)
Number of subjects: 120
Study: 9548121

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise until fatigued
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rested state
Number of subjects: 20
Study: 7808826

Group type: EXPERIMENTAL
Intervention: Nonadhesive semipermeable dressing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (untreated skin)
Number of subjects: 15
Study: 3400902

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (Medrol tablets, Upjohn)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Topical vasoconstrictor (oxymetazoline spray)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 29
Study: 30562068

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 9249

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9249
Study: 26681272

Group type: EXPERIMENTAL
Intervention: TachoSil patch
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no TachoSil patch)
Number of subjects: 101
Study: 24275775

Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (10 µg/mL), injected at 5.4 mL (54 µg epinephrine) for group I and 10.8 mL (108 µg epinephrine) for group II.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (108 µg) in group II.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mepivacaine 2% with epinephrine (54 µg) in group I.
Number of subjects: 26
Study: 23676529

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + Selective Serotonin Reuptake Inhibitor (CBT+SSRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CBT)
Number of subjects: 0
Study: 20639274

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle programme (e.g. physical exercise, smoking cessation, dietary advice, including stress management)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 130
Study: 18407943

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 36
Study: 16603428

Group type: EXPERIMENTAL
Intervention: GnRH agonist (flare-up) protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: GnRH antagonist protocol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups received exogenous LH (human menopausal gonadotropin)
Number of subjects: 30
Study: 14998094

Group type: EXPERIMENTAL
Intervention: Experiential anchoring technique (anchor group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Non-anchor group (control)
Number of subjects: 41
Study: 11148442

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 6
Study: 9752737

Group type: EXPERIMENTAL
Intervention: Uranoplasty (surgical intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive measures (aimed at removal or alleviation of alkalosis)
Number of subjects: 0
Study: 7824809

Group type: EXPERIMENTAL
Intervention: Formoterol, inhaled, twice daily for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Salbutamol, inhaled, four times daily for 12 weeks
Number of subjects: 99
Study: 3043414

Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Amniocentesis (GA)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Chorionic Villus Sampling (CVS) and Amniocentesis (GA)
Number of subjects: 511
Study: 31434144

Group type: EXPERIMENTAL
Intervention: Two-strand grafts (T group)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Four-strand grafts (F group)
Number of subjects: 76
Study: 29952176

Group type: EXPERIMENTAL
Intervention: 8-week jazz dance class (two times/week for 70 min per session)
Number of subjects: 90
Study: 28456146

Group type: EXPERIMENTAL
Intervention: Polypodium leucotomos/pomegranate combination (PPmix®) 480 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Polypodium leucotomos alone (Fernblock®) 480 mg/day
Number of subjects: 40
Study: 26297156

Group type: EXPERIMENTAL
Intervention: GnRH agonists (triptorelin injections of 0.1mg on the 4th and 6th day after progesterone introduction)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual progesterone supplementation
Number of subjects: 220
Study: 23663119

Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (150 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 21724628

Group type: EXPERIMENTAL
Intervention: Daily interruption of fentanyl and/or midazolam infusions for up to 6 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual management of sedation
Number of subjects: 50
Study: 19357910

Group type: EXPERIMENTAL
Intervention: BTX‐A (2.5 U per cubic centimeter of lesion) injected for a total of 3 months
Number of subjects: 19
Study: 16961787

Group type: EXPERIMENTAL
Intervention: Topiramate (25 mg to 100 mg daily, titrated by week 4)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 51
Study: 12764513

Group type: EXPERIMENTAL
Intervention: Shanghai Chronic Disease Self‐Management Program (CDSMP)
Number of subjects: 954

Group type: COMPARATOR
Intervention: Control group (waiting-list)
Number of subjects: 954
Study: 11071034

Group type: EXPERIMENTAL
Intervention: 0.15 mg clonidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 9305267

Group type: EXPERIMENTAL
Intervention: Full-length custom-made shoes with a total-contact insert, a rigid rocker-bottom sole
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Short shoe with a rigid rocker-bottom sole (with or without an ankle-foot-orthosis)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular shoes with a toe filler
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Short shoe and ankle-foot-orthosis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All footwear conditions
Number of subjects: 30
Study: 8369246

Group type: EXPERIMENTAL
Intervention: Misoprostol (100 micrograms inserted vaginally)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (similarly inserted)
Number of subjects: 45
Study: 3531295

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice daily
Number of subjects: 99

Group type: COMPARATOR
Intervention: Captopril 25 mg plus hydrochlorothiazide 15 mg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Captopril 50 mg twice daily
Number of subjects: 99
Study: 31964193

Group type: EXPERIMENTAL
Intervention: PUMPA‐TURP
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional TURP
Number of subjects: 80
Study: 30531187

Group type: EXPERIMENTAL
Intervention: Microfocused Ultrasound with Visualization (MFU-V)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Monopolar Radiofrequency (MRF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both MRF and MFU-V
Number of subjects: 20
Study: 28708420

Group type: EXPERIMENTAL
Intervention: 1.5 g/kg BW Tualang Honey (high honey; HH; n=10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.75 g/kg BW Tualang Honey (low honey; LH; n=10)
Number of subjects: 20
Study: 25822284

Group type: EXPERIMENTAL
Intervention: Patient-Centered Disease Management (PCDM) intervention
Number of subjects: 392

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 392
Study: 24376252

Group type: COMPARATOR
Intervention: Dietary Guidelines (DG) only group (n = 61)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Dietary Guidelines + Physical Activity (DG + PA) group (n = 60)
Number of subjects: 121
Study: 22804826

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin eardrops
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Boric acid powder
Number of subjects: 159

Group type: COMPARATOR
Intervention: 1% Acetic acid eardrops
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Quadriderm cream
Number of subjects: 159
Study: 18716827

Group type: EXPERIMENTAL
Intervention: Topical piroxicam
Number of subjects: 50

Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 50
Study: 18217459

Group type: EXPERIMENTAL
Intervention: Rice policosanol 10 mg/day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 15170705

Group type: EXPERIMENTAL
Intervention: Rotational angiography
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard angiography
Number of subjects: 56
Study: 11354594

Group type: EXPERIMENTAL
Intervention: 6‐month work rehabilitation program
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Neuropsychological variables
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Neuropsychological measures
Number of subjects: 33
Study: 9549666

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate (40 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modafinil and Methylphenidate (combination)
Number of subjects: 0
Study: 8045961

Group type: EXPERIMENTAL
Intervention: Goserelin (GnRH agonist) for 9 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Estrogen plus progestin replacement from the fourth month onward
Number of subjects: 20
Study: 2648890

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 100 mg suppository
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30421240

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Manual ventilation
Number of subjects: 62
Study: 29738179

Group type: EXPERIMENTAL
Intervention: Gujing Maisiha Tablets combined with natural vitamin E
Number of subjects: 135

Group type: COMPARATOR
Intervention: Natural vitamin E only (Control)
Number of subjects: 135
Study: 25874955

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Supportive psychotherapy (SPT)
Number of subjects: 80
Study: 23680241

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diabetic patients (4-7 years duration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-diabetic patients
Number of subjects: 20
Study: 21414223

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mononuclear bone marrow cells (mBMC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 19968014

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 51

Group type: COMPARATOR
Intervention: Attention Control (crossed over to CBT-I)
Number of subjects: 51
Study: 16828803

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 50 or 500 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 15176649

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg subcutaneously twice weekly for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Data from prior clinical studies (healthy subjects n=53, RA patients n=212)
Number of subjects: 43
Study: 15663647

Group type: EXPERIMENTAL
Intervention: Neoral (Novartis)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cysporin (Mayne Pharma)
Number of subjects: 38
Study: 10077095

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine injected by high-pressure technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine injected by low-pressure technique
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lidocaine without epinephrine injected under high pressure
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lidocaine without epinephrine injected under low pressure
Number of subjects: 20
Study: 7737398

Group type: EXPERIMENTAL
Intervention: Normal vision
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Eyes closed (remembered location of the target)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flanker objects present (wooden cylinder)
Number of subjects: 6
Study: 2285719

Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia
Number of subjects: 134

Group type: COMPARATOR
Intervention: Normal saline epidural solution
Number of subjects: 134
Study: 7306862

Group type: EXPERIMENTAL
Intervention: 4% methylcellulose
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paraffin-based oculentum simplex
Number of subjects: 120
Study: 31635962

Group type: EXPERIMENTAL
Intervention: Branches
Number of subjects: 158

Group type: COMPARATOR
Intervention: Fenestrations
Number of subjects: 158
Study: 31140402

Group type: EXPERIMENTAL
Intervention: Early endovenous ablation (compression therapy and superficial endovenous ablation within 2 weeks of randomisation)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Deferred endovenous ablation (compression therapy followed by endovenous ablation once the ulcer had healed)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Early endovenous ablation
Number of subjects: 450

Group type: COMPARATOR
Intervention: Deferred endovenous ablation
Number of subjects: 450
Study: 28891084

Group type: EXPERIMENTAL
Intervention: Dietitian group (DG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Physician group (PG)
Number of subjects: 100
Study: 26709105

Group type: EXPERIMENTAL
Intervention: ECG simulator program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional teaching
Number of subjects: 0
Study: 24356398

Group type: EXPERIMENTAL
Intervention: Full periodontal therapy (Group 1, n = 15)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No professional periodontal cleaning (Group 2, n = 10)
Number of subjects: 25
Study: 23202818

Group type: EXPERIMENTAL
Intervention: Plastic BioSand filter (BSF)
Number of subjects: 0
Study: 20815045

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 169
Study: 17945291

Group type: EXPERIMENTAL
Intervention: Desmopressin combined with 0.5 mg/kg furosemide daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Desmopressin alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dietary sodium and protein restriction
Number of subjects: 12
Study: 16256917

Group type: EXPERIMENTAL
Intervention: Scrub-and-paint (n = 115)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Paint-only (n = 119)
Number of subjects: 234
Study: 11830801

Group type: EXPERIMENTAL
Intervention: Live attenuated varicella vaccine
Number of subjects: 461
Study: 10190788

Group type: EXPERIMENTAL
Intervention: Paclitaxel 1-hour infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paclitaxel 3-hour infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estimation of glomerular filtration rate using age, height, plasma creatinine, and plasma creatine kinase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: p53 gene sequence analysis
Number of subjects: 0
Study: 7757101

Group type: EXPERIMENTAL
Intervention: White women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: White men
Number of subjects: 0

Group type: COMPARATOR
Intervention: Black women
Number of subjects: 0
Study: 31460771

Group type: EXPERIMENTAL
Intervention: Panchatikta Ghrita (PG) with calcium and vitamin D3 supplements
Number of subjects: 80

Group type: COMPARATOR
Intervention: Calcium and vitamin D3 supplements
Number of subjects: 80
Study: 28510346

Group type: EXPERIMENTAL
Intervention: Rivipansel 4 g by intravenous infusion over 20 minutes
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 26265201

Group type: EXPERIMENTAL
Intervention: CRIS with tailored printouts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRIS with standard information
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-contact group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRIS tailored group (ages 50 and older)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRIS nontailored group (ages 50 and older)
Number of subjects: 0
Study: 23353631

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Not treated with hydrochlorothiazide
Number of subjects: 2112
Study: 21975090

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 406

Group type: COMPARATOR
Intervention: Health education intervention
Number of subjects: 406
Study: 19906312

Group type: EXPERIMENTAL
Intervention: Multi-disciplinary orientation program including face-to-face introduction to hospital facilities, multi-disciplinary team, treatment side effects, and self-care strategies.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 16984385

Group type: EXPERIMENTAL
Intervention: DN-101 (high dose calcitriol) with docetaxel
Number of subjects: 250

Group type: COMPARATOR
Intervention: Docetaxel (placebo-controlled)
Number of subjects: 250